03/27/2024 8:48 AM | Johnson & Johnson (Subject) National Legal & Policy Center (Filed by)
| Form PX14A6G | |
03/13/2024 3:28 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 3:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 6:42 AM | Johnson & Johnson (Filer)
| Form ARS | |
03/13/2024 6:35 AM | Johnson & Johnson (Filer)
| Form DEF 14A | |
03/13/2024 6:37 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/13/2024 6:39 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
|
03/06/2024 2:42 PM | CVRx, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:58 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:54 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:12 PM | Johnson & Johnson (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 4:23 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
02/15/2024 3:53 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Warning: this could blow your mind (Ad) Buckle up…
‘Cause this might shatter everything you’ve heard about “income trading”.
In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it:
The Perfect Income Trade
You see, most of the income techniques out there target a couple of percent.
Maybe 5 - 10 percent if you’re lucky.
But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return.
And here’s the best news of all:
This trade can target an opportunity like that every week. Every single week.
Meaning an investor has the chance to “stack up” these more aggressive income trades over and over.
If that sounds interesting… Watch the presentation here |
02/09/2024 11:55 AM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 11:35 AM | Johnson & Johnson (Subject) Taubert Jennifer L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024 3:24 PM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:07 PM | BiomX Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:52 PM | CVRx, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:32 PM | Johnson & Johnson (Filed by) Johnson & Johnson (Filed by) Nanobiotix S.A. (Subject)
| Form SC 13G/A | |
01/30/2024 11:46 AM | Johnson & Johnson (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/29/2024 3:50 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/24/2024 11:51 AM | Johnson & Johnson (Filed by) Kenvue Inc. (Subject)
| Form SC 13G | |
01/23/2024 6:45 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 4:08 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 4:22 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 7:22 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
12/08/2023 3:33 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/07/2023 4:17 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:42 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 6:52 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 3:30 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 3:56 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/23/2023 3:48 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 6:33 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:36 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:46 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:02 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 3:53 PM | Johnson & Johnson (Reporting) Kenvue Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:04 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/23/2023 5:37 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/21/2023 5:52 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/21/2023 5:38 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/18/2023 4:11 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023 3:53 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023 5:23 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/16/2023 8:22 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/16/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/15/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/14/2023 3:44 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/11/2023 3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/04/2023 3:32 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 7:03 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/01/2023 3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/31/2023 3:06 PM | Johnson & Johnson (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/28/2023 7:59 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/27/2023 4:52 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/27/2023 4:52 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2023 3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject) Kenvue Inc. (Filed by)
| Form 425 | |
Did You Get Your Free Bitcoin Yet? (Ad) And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously.
Right now is a very important time to pay attention to what we are doing and what is happening.
If you wait... it will be too late.
This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject) Kenvue Inc. (Filed by)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:07 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 7:40 AM | Johnson & Johnson (Subject)
| Form 425 | |